Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery
Biomolecules · 2025
DOI: 10.3390/biom15060869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Cristian Gonzalez-Ruiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación Integral Cardiometabólica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Catechin, Neuroprotective Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Instituto Politécnico Nacional, IPN.
Abstract (Originalsprache)
Neurological damage from traumatic spinal cord injury (SCI) results in a grade of disability ranging from mild to severe motor and sensory dysfunction. It occurs more frequently in men of productive age. Treatment essentially consists of anti-inflammatories and rehabilitation. Other treatments are only partially effective, and inadequate treatment and secondary conditions often cause premature mortality. The search for pharmacological approaches is a continuous effort. This study aimed to assess the effects of a natural compound on spinal cord injury (SCI) as an alternative damage prevention maneuver. We evaluated the protective effects of the flavanol (+)-epicatechin (EC) in a rat model of moderate trauma-induced SCI on protein markers of damage events. The results showed that EC induced significant protection against SCI. No changes were found in angiopoietin-1, beclin-1, myelin basic protein, glial fibrillary acidic protein, neurofilament heavy polypeptide, and neuronal nuclear antigen after the injury, suggesting that damage progression was impeded. The reduction in damage translates into better movement. The results suggest that (+)-epicatechin may be a suitable alternative for treating SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Investigación Integral Cardiometabólica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de México, Tlalnepantla 54090, Mexico.
- Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06600, Mexico.
- School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
ORCID-Profile: Cristian Gonzalez-Ruiz, Rodrigo Mondragón-Lozano, Hermelinda Salgado-Ceballos, Yuridia Martínez-Meza, Nayelli Nájera, Guillermo Ceballos
Förderung
- BLRD VA
- Instituto Politécnico Nacional
- IPN
Zitieren
APA
Gonzalez-Ruiz, C., Mondragón-Lozano, R., Salgado-Ceballos, H., Villarreal, F., Martínez-Meza, Y., Meaney, E., Nájera, N., & Ceballos, G. (2025). Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery. Biomolecules. https://doi.org/10.3390/biom15060869
Vancouver
Gonzalez-Ruiz C, Mondragón-Lozano R, Salgado-Ceballos H, Villarreal F, Martínez-Meza Y, Meaney E, et al. Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery. Biomolecules. 2025. doi:10.3390/biom15060869
BibTeX
@article{GonzalezRuiz2025,
author = {Gonzalez-Ruiz, Cristian and Mondragón-Lozano, Rodrigo and Salgado-Ceballos, Hermelinda and Villarreal, Francisco and Martínez-Meza, Yuridia and Meaney, Eduardo and Nájera, Nayelli and Ceballos, Guillermo},
title = {Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15060869}
}
EUVIMED